Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subjects: Conference, Event, Webcast

Aldeyra to Present at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that President and CEO Todd C. Brady, M.D., Ph.D., Chief Financial Officer Joshua Reed, and Chief Commercial Officer David McMullin will be participating in a fireside chat and hosting one-on-one meetings at Oppenheimer's Fall Healthcare Life Sciences & MedTech Summit, which is being held in a virtual format.

The fireside chat is scheduled to begin at 2:30 p.m. ET Wednesday, September 23, 2020. A live webcast of the event will be available on the investor relations page of the company's corporate website at https://ir.aldeyra.com. After the live webcast, the event will remain archived on the Aldeyra Therapeutics website for 90 days.

About Aldeyra Therapeutics

Aldeyra Therapeutics is a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with immune-mediated diseases. Two of the company's lead compounds, reproxalap and ADX-629, target reactive aldehyde species (RASP), which are elevated in ocular and systemic inflammatory disease and result in cytokine release via activation of a broad array of inflammatory factors, including NF-?B, inflammasomes, and Scavenger Receptor A. Reproxalap is being evaluated in Phase 3 clinical trials in patients with dry eye disease and allergic conjunctivitis. The company's clinical pipeline also includes ADX-2191, a dihydrofolate reductase inhibitor in Phase 3 testing for proliferative vitreoretinopathy, and ADX-1612, a chaperome inhibitor in development for COVID-19 and ovarian cancer. For more information, visit https://www.aldeyra.com/ and follow us on LinkedIn, Facebook, and Twitter.

These press releases may also interest you

at 07:20
Science Applications International Corp. today announced the availability of the SAIC R3 portfolio of solutions designed to help federal government customers meet new work challenges and opportunities related to remote work, resiliency, and digital...

at 07:20
The "Aluminium Flat Products - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering. Global Aluminium Flat Products Market accounted for $54.6 billion in 2019 and is expected to reach $93.81 billion by 2027,...

at 07:15
The "Medical Fiber Optics - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering. Global Medical Fiber Optics Market accounted for $784.33 million in 2019 and is expected to reach $1,388.47 million by 2027,...

at 07:15
The "T-Cell Immunotherapy Market Research Report by Mechanism Of Action, by Product Class - Global Forecast to 2025 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering. The Global T-Cell Immunotherapy Market...

at 07:15
Care Value, Inc., ("CareValue"), based in Canandaigua, New York, has announced that they will be offering EmblemHealth and ConnectiCare Medicare products for online enrollments on MedicareValue.com. MedicareValue, owned by CareValue, is a compliant,...

at 07:13
Frost & Sullivan's recent analysis, Opportunities and Use Cases for Autonomous Trucking, Forecast to 2040, maps the autonomous technology roadmap and market trends in the two leading regions: North America and the European Union. Level 1 features are...

News published on 16 september 2020 at 08:05 and distributed by: